Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or
recurrence of cancer. Celecoxib may be effective in preventing breast cancer in at-risk
women.
PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing breast cancer
in premenopausal women who are at risk of developing cancer.